logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Ramón y Cajal Hospital

+34913368000
Source: Site record.
https://www.comunidad.madrid/hospital/ramonycajal

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Hospital Universitario Ramón y Cajal is a premier, publicly owned tertiary teaching hospital located in the Valverde neighborhood of northern Madrid, Spain. Inaugurated on 18 October 1977, the hospital serves an urban population of over 570,000 residents and operates as a central node in the Madrid Health Service (SERMAS) network. It features a large-scale infrastructure with approximately 1,250 beds and nearly 6,000 professionals. Named after Santiago Ramón y Cajal—the pioneering Spanish neurohistologist and Nobel laureate—the institution stands out nationally for its integrated Research Department comprising four specialized services: Bioelectromagnetism, Histology, Biochemistry, and Neurobiology.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. Dermatologist
Source: Human-provided. General hospital
Source: Trial-derived.
716Total Trials
Source: Trial-derived.
135Recruiting Trials
Source: Trial-derived.
314Active Trials
Source: Trial-derived.
302Completed Trials
Source: Trial-derived.
867Unique Conditions
Source: Trial-derived.
472Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (26)Source: Trial-derived. Thyroid Eye Disease (12)Source: Trial-derived. Endometrial Cancer (10)Source: Trial-derived. Ovarian Cancer (10)Source: Trial-derived. Heart Failure (9)Source: Trial-derived. Multiple Myeloma (9)Source: Trial-derived. Breast Neoplasms (8)Source: Trial-derived. Melanoma (8)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (54)Source: Trial-derived. Eli Lilly and Company (38)Source: Trial-derived. AbbVie (36)Source: Trial-derived. Pfizer (36)Source: Trial-derived. Hoffmann-La Roche (29)Source: Trial-derived. Amgen (27)Source: Trial-derived. Gilead Sciences (25)Source: Trial-derived. Boehringer Ingelheim (21)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported
Source: AI-inferred. Emergency department support

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Remote informed consent

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. MRI
Source: AI-inferred. Spirometry
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. Echocardiography
Source: AI-inferred. PET-CT

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Exophthalmometry (proptosis measurement)
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. Exophthalmometry
Source: AI-inferred. Audiometric hearing assessment
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. CAR-T cell therapy administration
Source: AI-inferred. Electronic patient-reported outcome diary (ePRO)
Source: AI-inferred. KIT D816V mutation allele burden testing